Positive Allosteric Modulators of SERCA Pump Restore Dendritic Spines and Rescue Long-Term Potentiation Defects in Alzheimer’s Disease Mouse Model
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241813973 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Anastasiya Rakovskaya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Neurodegeneration, Peter the Great St. Petersburg Polytechnical University, St. Petersburg 195251, Russia. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Russian Science Foundation, National Institutes of Health.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a neurodegenerative disorder that affects memory formation and storage processes. Dysregulated neuronal calcium (Ca2+) has been identified as one of the key pathogenic events in AD, and it has been suggested that pharmacological agents that stabilize Ca2+ neuronal signaling can act as disease-modifying agents in AD. In previous studies, we demonstrated that positive allosteric regulators (PAMs) of the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) pump might act as such Ca2+-stabilizing agents and exhibit neuroprotective properties. In the present study, we evaluated effects of a set of novel SERCA PAM agents on the rate of Ca2+ extraction from the cytoplasm of the HEK293T cell line, on morphometric parameters of dendritic spines of primary hippocampal neurons in normal conditions and in conditions of amyloid toxicity, and on long-term potentiation in slices derived from 5xFAD transgenic mice modeling AD. Several SERCA PAM compounds demonstrated neuroprotective properties, and the compound NDC-9009 showed the best results. The findings in this study support the hypothesis that the SERCA pump is a potential therapeutic target for AD treatment and that NDC-9009 is a promising lead molecule to be used in the development of disease-modifying agents for AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Molecular Neurodegeneration, Peter the Great St. Petersburg Polytechnical University, St. Petersburg 195251, Russia.
- Neurodon Corporation, 9800 Connecticut Drive, Crown Point, IN 46307, USA.
- Department of Physiology, UT Southwestern Medical Center at Dallas, Dallas, TX 75390, USA.
ORCID-Profile: Alexander Erofeev, Egor Vinokurov, Ilya Bezprozvanny
Förderung
- NIA NIH HHS
- Russian Science Foundation
- National Institutes of Health
- Neurodon Corporation
Zitieren
APA
Rakovskaya, A., Erofeev, A., Vinokurov, E., Pchitskaya, E., Dahl, R., & Bezprozvanny, I. (2023). Positive Allosteric Modulators of SERCA Pump Restore Dendritic Spines and Rescue Long-Term Potentiation Defects in Alzheimer’s Disease Mouse Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241813973
Vancouver
Rakovskaya A, Erofeev A, Vinokurov E, Pchitskaya E, Dahl R, Bezprozvanny I. Positive Allosteric Modulators of SERCA Pump Restore Dendritic Spines and Rescue Long-Term Potentiation Defects in Alzheimer’s Disease Mouse Model. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241813973
BibTeX
@article{Rakovskaya2023,
author = {Rakovskaya, Anastasiya and Erofeev, Alexander and Vinokurov, Egor and Pchitskaya, Ekaterina and Dahl, Russell and Bezprozvanny, Ilya},
title = {Positive Allosteric Modulators of SERCA Pump Restore Dendritic Spines and Rescue Long-Term Potentiation Defects in Alzheimer’s Disease Mouse Model},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241813973}
}
EUVIMED